Key levels and trade conditions
Delayed quotes · Technical conditionsShowing the near-term range, based on the latest 5 completed sessions and updated after each close.
Hold and monitor; no addition yet
Signals require closing-price and volume confirmation; review the company research below before acting.
When does defense take priority?
Close beyond this level with session volume ≥ 1.5× the previous 20 completed sessions’ average.
Confirmed close below $54.56 → consider reducing
When to consider adding?
Close beyond this level with session volume ≥ 1.5× the previous 20 completed sessions’ average.
Confirmed close above $64.06 → consider a staged addition
01Newstock overall assessment
The conclusion first, followed by the evidence that matters most.
ENTRY CONCLUSION
Watch — hold off on buying the dip
The valuation margin of safety, technical confirmation and market/estimate conditions are not all satisfied. No entry signal is issued.
The research does not currently establish an actionable entry price. Do not buy solely because the stock has fallen sharply; wait for the key conditions to be verified before reconsidering entry.
Why
Intel is in a repair phase, but the durability of that repair is not yet proven. Q3 2026 guidance calls for revenue of $15.8–16.8B, which shows growth has not rolled over, yet Q2 net loss was still $(11.0)B and “Interest and other, net” was a major drag, leaving financial quality fragile. On the balance sheet, cash and cash equivalents were $12.874B and short-term investments $16.853B, so liquidity is adequate; however, total interest-bearing debt was $48.549B plus $1.988B of short-term debt, and the combination of heavy capex and foundry execution risk keeps leverage constraints meaningful. Technically, the stock is not in a confirmed reversal: it closed at $92.07 below MA20 and MA60, the trend is down, and CMF20 is negative with heavier volume, so the rebound is not trend-confirmed. The positive offset is Nasdaq consensus target of $94.56, next-quarter EPS consensus of $0.28, and positive revisions, which support near-term sentiment; but those consensus signals do not override the earnings and balance-sheet constraints.
Research as of 2026-10-30T13:28:01.411Z · Research conclusion, not a real-time trading signal · Outdated; update before reassessing
02What happened recently
Company events, industry developments and market conditions — facts separated from possible explanations.
US 10Y yield 5.13%2026-11-13T16:08:54.000Z
VIX 20.222026-11-13T16:08:46.000Z
Dollar index 103.362026-11-13T16:14:00.000Z
Market and sector reference
INTC -5.66% · SPY -1.13% · Peer average -6.90% (ADI, AMD, ARM, AVGO, CRDO, GFS)
2026-11-13T16:24:07.000Z · Yahoo · Aligned-session reference, not a causal attribution.
Related news and impact paths
Recent news related to this stock
50 direct · 19 2nd-order · 0 thematicRanked by model assessment and recency. Labels use the original model impact, not expected returns. Impact percentages are model estimates, not observed price changes, probabilities or guaranteed returns.
- #1Impact18%AdverseDirectStock Market Today, Oct. 30: Intel Plunges Nearly 29% as Weak Outlook Rattles Wall Street14d ago
With revenue still at $52.9B but net income negative and gross margin only 34.8%, the weak outlook signals that top-line recovery is not translating into profits fast enough, forcing another reset in the valuation multiple on its foundry and AI turnaround.
Also named: AMD · QCOM · MU · TSM · ASML · AMAT
The market will read the weak outlook as a sign that foundry ramp, yields and customer onboarding are lagging expectations, pressuring several quarters of revenue and free-cash-flow valuation.
Also named: AMD · NVDA · AVGO · TSM · ASML · HPQ
- #3Impact12%AdverseDirectIntel Plunges 29% on Weak Outlook as Tech Selloff Deepens | Closing Bell14d ago
The company’s outlook came in below the high-confidence consensus for next-quarter EPS of $0.28, and its history of large beats had already been priced in; the weaker guide implies the earnings recovery may be materially slower than investors expected.
Also named: AMD · NVDA · QCOM · MSFT · AMZN · ORCL
The company itself cut guidance, forcing the market to lower revenue, gross-margin and free-cash-flow expectations while discounting its foundry and product-transition story further.
Also named: AMD · NVIDIA · QUALCOMM · TSMC · DELL · HPE
A strong data center print does not automatically translate into profit conversion; investors are more concerned that heavy capex, margin recovery and foundry investment will keep weighing on valuation.
Also named: AMD · NVIDIA · BROADCOM · MSFT · AMZN · GOOGL
Intel’s foundry pivot still requires heavy capex, but with profitability weak and gross-margin repair limited, investors are likely to question whether the unit can reach scale economics on a reasonable timeline.
Also named: TSM · 005930.KS · AMAT · LRCX · ASML · KLAC
- #7Impact8.5%AdverseDirectIntel's Shares Plunge 20% as A.I. Hinders Some Parts of Its Business15d ago
The company explicitly said AI is hurting parts of the business, and with gross margin only 34.8% and full-year earnings still near breakeven, the market will cut its expected pace of profit recovery in data center and turnaround operations.
Also named: AMD · NVIDIA · TSMC · DELL · HPE · SMCI
Foundry is extremely capital-intensive; the tighter the cash flow, the more investors question customer traction and line ramp-up.
Also named: AMD · NVDA · TSM · ASML · AMAT
- #9Impact5.8%AdverseDirectIntel Stock Has Plunged 50% in a Month. Trump's Bad Week Is Getting Worse.8d ago
The foundry pivot is a core part of Intel’s valuation, and the selloff directly lowers the market’s discounting of successful foundry commercialization.
Also named: AMD · NVDA · QCOM · TSM · SMIC · AMAT
- #10Impact5.8%AdverseDirectNasdaq futures tumble as Amazon, Intel results deepen AI spending woes14d ago
Intel's revenue base is large, but profitability and earnings quality remain fragile; any cautious commentary on AI server/PC demand or process investment returns directly lowers expectations for earnings recovery.
Also named: AMZN · MSFT · GOOGL · NVDA · AMD · ASML
The rest, archived by time · 59
03Is the company worth considering?
Business quality, financials, valuation and analyst disagreements.
🏛️ Company factsSEC filings + FINRA official data
Annual revenue $52.9B · latest quarter up 20.9% YoY · reported FY net loss of $267M · short-sale volume share near its recent available-day average.
FY revenue
$52.9B
2025-12
Latest Q YoY
+20.9%
Gross margin
34.8%
FY net loss
$267M
Diluted EPS
$-0.06
Short-sale volume share
36%
2026-11-05 · Recent available-day avg 37.6% · near recent average
Short-sale volume as a share of trades covered by the FINRA file, not all market trading or outstanding short positions. Changes do not establish that short sellers are adding or covering positions.
Historical results versus analyst expectations
🎯 Market expectations
Estimate context score Medium · 54/100Nasdaq analyst consensus · currently available data
- Sep 2026$0.41 vs $0.28+46.43%
- Jun 2026$0.30 vs $0.10+200%
- Mar 2026$0.17 vs -$0.10+270%
- Dec 2025$0.04 vs -$0.02+300%
The takeaway
EPS exceeded the corresponding consensus estimates by an average of 204.1% in the quarters shown. This is not a hurdle for the next report or a forecast of the stock's reaction. Analysts made 11 downward revisions over the past four weeks.
Analyst estimates, not our forecast · not investment advice
Analyst consensus and disagreement
Target-price summary $70.00–$145.00 · Consensus $90.93
Buy / hold / sell 7 / 24 / 1
Nasdaq · Retrieved 2026-11-13T16:24:10.882Z · The aggregate does not provide individual report dates or original theses. It does not establish undervaluation; no analyst rationale is inferred. Targets are not guaranteed outcomes.
Next-quarter EPS estimate (Dec 2026) $0.15 · $0.11–$0.17 · 12 analysts
Four-week estimate revisions: up / down 0 / 11
Estimate dispersion 40.0%
Nasdaq EPS forecasts · retrieved 2026-11-13T16:24:10.829ZFinancial inputs and original sources
gpt-5.4-mini · 2026-10-30T13:28:01.411Z · AI-generated and checked, not an independent human audit
Cash: 12.874 USD_millions · 2026-06-27
“Cash and cash equivalents $ 12,874”
Debt: 48.549 USD_millions · 2026-06-27
“Debt 48,549”
Fully diluted shares: 5104 shares_millions · 2026-06-27
“Weighted average shares of common stock outstanding: Basic 5,104 Diluted 5,104”
04Is now a good time?
Trend, moving averages, volume and key price levels — not the decline alone.
Technical structure · Downtrend structure
MA5 $59.50
MA10 $59.43
MA20 $75.25
MA60 $94.60
Last completed-session close $61.20 (-2.08%) · Volume / prior 20-session average 0.53×
Prior 20-session range $51.51–$96.87 · MA20 change over five sessions -11.98% · CMF20 -0.17
- Distribution-like weak closes (inference)
Confirmation to watch: a close above $96.87 with volume at least 1.5× the prior 20-session average. A heavy-volume break below $51.51 weakens the setup.
Completed daily candles only. Daily OHLCV cannot establish accumulation, shakeout or manipulation intent; CMF is a price/volume proxy, not actual fund flows. Thresholds are research rules, not validated success probabilities. Yahoo · 2026-11-12
Price and news
Historical prices and volume. Drag to pan; scroll to zoom.
Related news
05What would change our assessment?
Conditions for reconsidering entry and developments that invalidate the thesis.
When to reconsider
- The stock needs to reclaim MA20, with MA20 flattening or turning up, to show the short-term trend is repairing.
- Volume should be at or above the 20-day average, while price holds the $84.65 support level, indicating the pullback has not damaged the structure.
- The next earnings release/guidance must keep revenue within the current range and show gross margin and operating efficiency are no longer deteriorating.
- Foundry capacity, yield, and customer ramp milestones need to keep progressing without new financing stress or additional equity dependence.
What would invalidate the thesis
- A decisive break below the $84.65 support level, especially if MA60 is also lost, would put the downtrend back in control.
- Subsequent earnings or guidance show revenue rolling over, gross margin weakening, or operating efficiency under renewed pressure.
- Free cash flow weakens again, or capex and debt-service pressure rise enough to revive financing concerns.
- Meaningful delays in foundry execution, customer ramps, or key projects would offset the valuation-repair thesis.
Additional risk evidence and model detail
Market View
Crowding
Risk temperature
Tail risk
Triggers
Price and volume
Insider signals
See every affected stock, second-order impact and risk factor. Try Pro free for 7 days — no credit card required.
Start my free trial